The Promise and Challenges of Organoids in Disease Research
In this Labcompare article, Aaron Risinger, Director of Business Development for Cellular Workflow Automation at Molecular Devices, explores the transformative potential and current hurdles of organoid technology in disease research. He explains how organoids offer far more physiological relevance than traditional 2D cultures or animal models, and how integrating automation and AI is key to scaling production, improving reproducibility, and enabling personalized medicine strategies.